封面
市場調查報告書
商品編碼
1968073

全球心臟封堵器市場規模、佔有率、趨勢和成長分析報告(2026-2034年)

Global Heart Closure Devices Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 169 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計心臟閉合裝置市場將從 2025 年的 51.2 億美元成長到 2034 年的 199 億美元,2026 年至 2034 年的複合年成長率為 16.29%。

由於心血管疾病仍是全球主要死因之一,全球心臟封堵器設備市場正穩定成長。心房中隔缺損(ASD)和卵圓孔未閉合(PFO)封堵系統等器械因其微創手術優勢和改善患者預後而備受關注。人們對結構性心臟疾病的認知不斷提高以及早期診斷技術的進步,進一步推動了市場滲透。

成長要素包括設備設計的技術進步、老年人口的成長以及獲得先進心臟護理服務的途徑增加。微創導管手術可縮短住院時間和復原時間,從而鼓勵患者和醫療服務提供者選擇封閉式設備。已開發國家優惠的健保報銷政策也促進了市場滲透。

隨著產品不斷創新和臨床研究的不斷拓展,未來前景十分樂觀。隨著醫療基礎設施的不斷完善,新興市場可望提供盈利的成長機會。由於介入性心臟病學的進步以及患者對微創治療日益成長的偏好,心臟封堵器械市場將保持穩定成長。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球心臟封堵器市場:依產品分類

  • 市場分析、洞察與預測
  • 心房中膈缺損症(ASD)封堵裝置
  • 室間隔缺損(VSD)封堵裝置
  • 卵圓通暢性閉合裝置
  • 左心耳封堵裝置
  • 其他產品

第5章 全球心臟封堵器市場:依材料分類

  • 市場分析、洞察與預測
  • 基於鎳鈦諾的裝置
  • 不銹鋼裝置
  • 其他材料

第6章:全球心臟封堵器市場:依輸送方式分類

  • 市場分析、洞察與預測
  • 經導管輸送
  • 手術分娩

第7章 全球心臟封堵器市場:依最終用途分類

  • 市場分析、洞察與預測
  • 醫院
  • 門診手術中心(ASC)
  • 心臟導管檢查室
  • 其他最終用戶

第8章 全球心臟封堵器市場:依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第10章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Abbott Laboratories
    • AtriCure
    • Biosense Webster
    • Boston Scientific Corporation
    • Cardia
    • Heartstitch
    • Lepu Medical Technology(Beijing)Co. Ltd
    • LifeTech Scientific Corporation
    • Medtronic
    • Occlutech
    • SentreHEART
    • Starway Medical Technology
    • WL Gore & Associates
簡介目錄
Product Code: VMR112110164

The Heart Closure Devices Market size is expected to reach USD 19.90 Billion in 2034 from USD 5.12 Billion (2025) growing at a CAGR of 16.29% during 2026-2034.

The Global Heart Closure Devices Market is growing steadily as cardiovascular disorders remain a leading cause of mortality worldwide. Devices such as atrial septal defect (ASD) and patent foramen ovale (PFO) closure systems are gaining traction due to minimally invasive procedures and improved patient outcomes. Increasing awareness and early diagnosis of structural heart defects are further boosting market adoption.

Key growth drivers include technological advancements in device design, rising geriatric populations, and expanding access to advanced cardiac care. Minimally invasive catheter-based procedures reduce hospital stays and recovery times, encouraging both patients and healthcare providers to opt for closure devices. Favorable reimbursement policies in developed economies also support market penetration.

Future prospects appear strong with continuous product innovation and expanding clinical research. Emerging markets are expected to offer lucrative growth opportunities due to improving healthcare infrastructure. As interventional cardiology evolves and patient preference shifts toward less invasive treatments, the heart closure devices market will maintain steady upward momentum.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Atrial Septal Defect (ASD) Closure Devices
  • Ventricular Septal Defect (VSD) Closure Devices
  • Patent Foramen Ovale (PFO) Closure Devices
  • Left Atrial Appendage (LAA) Closure Devices
  • Other Products

By Material

  • Nitinol-Based Devices
  • Stainless Steel Devices
  • Other Materials

By Mode of Delivery

  • Transcatheter Delivery
  • Surgical Delivery

By End Use

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Cardiac Catheterization Laboratories
  • Other End Users

COMPANIES PROFILED

  • Abbott Laboratories, AtriCure, Biosense Webster, Boston Scientific Corporation, Cardia, Heartstitch, Lepu Medical Technology Beijing Co Ltd, LifeTech Scientific Corporation, Medtronic, Occlutech, SentreHEART, Starway Medical Technology, W L Gore Associates
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEART CLOSURE DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Atrial Septal Defect (ASD) Closure Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Ventricular Septal Defect (VSD) Closure Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Patent Foramen Ovale (PFO) Closure Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Left Atrial Appendage (LAA) Closure Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Other Products Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEART CLOSURE DEVICES MARKET: BY MATERIAL 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Material
  • 5.2. Nitinol-Based Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Stainless Steel Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Other Materials Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEART CLOSURE DEVICES MARKET: BY MODE OF DELIVERY 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Mode Of Delivery
  • 6.2. Transcatheter Delivery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Surgical Delivery Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HEART CLOSURE DEVICES MARKET: BY END USE 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End Use
  • 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Ambulatory Surgical Centers (ASCs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Cardiac Catheterization Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL HEART CLOSURE DEVICES MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Product
    • 8.2.2 By Material
    • 8.2.3 By Mode Of Delivery
    • 8.2.4 By End Use
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Product
    • 8.3.2 By Material
    • 8.3.3 By Mode Of Delivery
    • 8.3.4 By End Use
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Product
    • 8.4.2 By Material
    • 8.4.3 By Mode Of Delivery
    • 8.4.4 By End Use
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Product
    • 8.5.2 By Material
    • 8.5.3 By Mode Of Delivery
    • 8.5.4 By End Use
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Product
    • 8.6.2 By Material
    • 8.6.3 By Mode Of Delivery
    • 8.6.4 By End Use
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL HEART CLOSURE DEVICES INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Abbott Laboratories
    • 10.2.2 AtriCure
    • 10.2.3 Biosense Webster
    • 10.2.4 Boston Scientific Corporation
    • 10.2.5 Cardia
    • 10.2.6 Heartstitch
    • 10.2.7 Lepu Medical Technology (Beijing) Co. Ltd
    • 10.2.8 LifeTech Scientific Corporation
    • 10.2.9 Medtronic
    • 10.2.10 Occlutech
    • 10.2.11 SentreHEART
    • 10.2.12 Starway Medical Technology
    • 10.2.13 W. L. Gore & Associates